Why It Matters
The Senate Committee on Health, Education, Labor and Pensions voted to move Dr. Erica Schwartz’s nomination as CDC director to the full Senate floor, clearing a significant hurdle for Trump’s leadership of the nation’s disease control agency. The committee’s approval follows a contentious hearing centered on vaccine policy and concerns about political interference in public health decisions.
What Happened
The committee voted 13–10 to advance Schwartz’s nomination in July, with all Republican members supporting the measure. Senator Tim Kaine of Virginia was the sole Democrat to vote in favor of the nomination, breaking ranks with his party colleagues who opposed the advancement.
During the confirmation hearing earlier in the month, senators from both parties questioned Schwartz on vaccine policy and the extent of political influence in CDC operations. The hearing highlighted deep disagreements over the agency’s independence and decision-making processes under a Trump administration led by HHS Secretary Robert F. Kennedy Jr.
Schwartz’s background includes service as an occupational medicine physician in the U.S. Navy and the U.S. Public Health Service Commissioned Corps, where she achieved the rank of rear admiral. She also served as chief medical officer of the U.S. Coast Guard and as deputy surgeon general of the United States.
Committee Chair Senator Bill Cassidy expressed confidence in Schwartz following the hearing. “After speaking with Dr. Schwartz again after the hearing, reviewing the transcript and speaking to those who have served with her and know her well, I’m confident that she knows what she is doing and will stand against those who do not,” Cassidy said.
By the Numbers
13–10 — Committee vote margin in favor of advancing Schwartz’s nomination
1 — Number of Democrats voting to advance the nomination (Senator Tim Kaine)
Zoom Out
The CDC directorship has become a flashpoint in broader debates over public health authority and the Trump administration’s approach to disease control policy. The nomination of Schwartz comes as Kennedy, as HHS Secretary, has signaled intent to reshape federal health agencies. Former CDC Director Susan Monarez testified before the Senate panel in September that she was fired for resisting Kennedy’s directives regarding vaccines, underscoring the tensions between career public health officials and the current administration’s priorities.
What’s Next
Schwartz’s nomination advances to the full Senate for a floor vote. Her confirmation would give Trump direct control over the CDC at a time when the agency faces questions about its independence and its relationship to the broader Trump health agenda. The full Senate vote will test whether Kaine’s support signals broader bipartisan backing or remains an outlier.